MTOR and hepatocellular carcinoma: The findings revealed that circRNA‐mTOR promoted the proliferation and clone formation of lenvatinib‐treated HCC cells while reducing their apoptosis rates compared to those of the control group (Figure 4B–D; Figure S2B–D, Supporting Information).